Good question. Of course, it would really be good to know where the funds are coming from and if there is a cost sharing partnership involved in order to come up with profit numbers. Also, if ours is better would it deserve a premium for better efficacy or a lower number of doses needed over time?

I would love to think a few dollars of profit but even $1 per unit would be a lot to a small company like GNBT/NGIO.